FAP and neoplasm: In particular, since 2018, researchers from the University of Heidelberg showed that DOTA-containing FAP inhibitors (FAPI) can be coupled with Gallium-68 and used for diagnostic PET imaging of multiple tumor entities, such as breast, colon, lung and pancreatic cancer [10,11].